{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:54:58Z","timestamp":1781499298586,"version":"3.54.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Disruptions to routine care and non-pharmacological interventions during the COVID-19 pandemic placed significant stress on dementia care in South Korea\u2019s long-term care (LTC) hospitals, which operate under a medicalized, insurance-integrated structure with high reliance on pharmacologic symptom management. However, limited research has examined whether psychotropic use increased in Korean LTC hospitals during the pandemic and whether changes persisted after the early pandemic period among older adults with dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A national longitudinal study was conducted using Korean National Health Insurance Service claims data for 385,602 older adults (\u2265 65\u202fyears) with dementia hospitalized in LTC hospitals from 2019, Quarter 4 to 2021, Quarter 4. Quarterly psychotropic use was assessed using prescription days and defined daily doses (DDDs), each standardized per 100 inpatient-days. Linear mixed models with LTC-hospital random intercepts were used to estimate quarterly trends, adjusting for facility and patient-level factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the 2019Q4 baseline, adjusted prescription days and DDDs increased for all psychotropic classes (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001). Antipsychotic medications showed the largest increases, peaking in 2021Q1 [2.67\u202fdays (95% CI 2.26\u20133.12) and 0.57 DDDs (95% CI 0.48\u20130.68)] and remaining above baseline in 2021Q4 [0.27\u202fdays (95% CI 0.06\u20130.50) and 0.09 DDDs (95% CI 0.03\u20130.16)], although diminishing in the later quarters. Anxiolytics and antidepressants also increased, with larger early-pandemic rises for anxiolytics [e.g., 2020Q1: 0.17\u202fdays (95% CI 0.12\u20130.22) and 0.10 DDDs (95% CI 0.07\u20130.14)] and steady increases for antidepressants through 2021Q4 [0.14\u202fdays (95% CI 0.10\u20130.19) and 0.09 DDDs (95% CI 0.07\u20130.12)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Psychotropic use remained elevated above pre-pandemic baseline levels through 2021, although increases attenuated substantially in the later quarters, particularly for antipsychotics. These findings suggest increased reliance on pharmacologic symptom management when routine psychosocial dementia care was constrained. Strengthening crisis-resilient, person-centered dementia care in LTC hospitals, including continuity of non-pharmacological interventions, staffing supports, and psychotropic stewardship and monitoring beyond antipsychotics, may reduce psychotropic reliance during public health emergencies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1776066","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:27:40Z","timestamp":1781497660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in psychotropic use among older adults with dementia in Korean long-term care hospitals across the COVID-19 pandemic: a national longitudinal study"],"prefix":"10.3389","volume":"14","author":[{"given":"Eunjin","family":"Kim","sequence":"first","affiliation":[{"name":"College of Nursing, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Yoon","sequence":"additional","affiliation":[{"name":"College of Nursing, Ewha Womans University","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Trinkoff","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Maryland","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40266-022-00992-5","article-title":"Implications of adverse outcomes associated with antipsychotics in older patients with dementia: a 2011-2022 update","volume":"40","author":"Rogowska","year":"2023","journal-title":"Drugs Aging"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses","volume":"7","author":"Tampi","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"ref5","year":"2017"},{"key":"ref6","year":"2025"},{"key":"ref7","year":"2020"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12877-021-02526-x","article-title":"Health-economic burden of dementia in South Korea","volume":"21","author":"Shon","year":"2021","journal-title":"BMC Geriatr"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4235\/agmr.20.0036","article-title":"Long-term care system in Korea","volume":"24","author":"Ga","year":"2020","journal-title":"Ann Geriatr Med Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijerph18020376","article-title":"Socioeconomic costs of dementia based on utilization of health care and long-term-care services: a retrospective cohort study","volume":"18","author":"Han","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref11","article-title":"Long-term care providers and services users in the United States, 2015-2016","author":"Harris-Kojetin","year":"2019","journal-title":"Vital Health Stat"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3928\/00989134-20201012-03","article-title":"Person-centered care plans for nursing home residents with behavioral and psychological symptoms of dementia","volume":"46","author":"Sefcik","year":"2020","journal-title":"J Gerontol Nurs"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.apnu.2015.06.004","article-title":"The association between the burden on formal caregivers and behavioral and psychological symptoms of dementia (BPSD) in Korean elderly in nursing homes","volume":"29","author":"Song","year":"2015","journal-title":"Arch Psychiatr Nurs"},{"key":"ref14","year":"2019"},{"key":"ref15","first-page":"2186","article-title":"COVID-19 6-month outbreak infection report as of July 19, 2020, in the Republic of Korea","volume":"13","author":"Park","year":"2020","journal-title":"Public Health Wkly"},{"key":"ref16","author":"Kim","year":"2020"},{"key":"ref17","first-page":"482","article-title":"Coronavirus disease-19 (COVID-19) one-year outbreak major cluster infection report as of January 19, 2021, in the Republic of Korea","volume":"14","author":"Jang","year":"2021","journal-title":"Public Health Wkly"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.12799\/rcphn.2023.00409","article-title":"Experience of nurses responding to the COVID-19 outbreak at a long-term care hospital in Korea","volume":"35","author":"Kim","year":"2024","journal-title":"Res Community Public Health Nurs"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jgs.18116","article-title":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID-19","volume":"71","author":"Coe","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40266-022-00948-9","article-title":"Psychotropic drug prescription in nursing homes during the COVID-19 pandemic","volume":"39","author":"Ferro Uriguen","year":"2022","journal-title":"Drugs Aging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jamda.2023.09.009","article-title":"Psychotropic, anticonvulsant, and opioid use in assisted living residents before and during the COVID-19 pandemic","volume":"25","author":"Maxwell","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/25424823261435562","article-title":"Association between the coronavirus disease pandemic and antipsychotic drug prescriptions among patients with dementia","volume":"10","author":"Hurh","year":"2026","journal-title":"J Alzheimers Dis Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1186\/s12877-024-05563-4","article-title":"Psychotropic use for behavioral and psychological symptoms of dementia during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"24","author":"Yoon","year":"2024","journal-title":"BMC Geriatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research","volume":"11","author":"Kyoung","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"ref25","article-title":"Guidelines for non-contact visitation in long-term care hospitals","year":"2020"},{"key":"ref26","year":"2021"},{"key":"ref27","year":"2018"},{"key":"ref28","year":"2024"},{"key":"ref29","year":"2023"},{"key":"ref30","year":""},{"key":"ref31","article-title":"Standardized guide to disease and medical practice statistical calculations","year":"2023"},{"key":"ref32","author":"Chang","year":"2021"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.4135\/9781483384450","volume-title":"Hierarchical Linear Modeling: Guide and Applications","author":"Garson","year":"2013"},{"key":"ref34","year":"2009"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamapsychiatry.2022.4448","article-title":"Rates of antipsychotic drug prescribing among people living with dementia during the COVID-19 pandemic","volume":"80","author":"Luo","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"CD003476","DOI":"10.1002\/14651858.CD003476.pub2","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer's disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jama.2021.1195","article-title":"Prevalence of central nervous system-active polypharmacy among older adults with dementia in the US","volume":"325","author":"Maust","year":"2021","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e190828","DOI":"10.1001\/jamanetworkopen.2019.0828","article-title":"Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis","volume":"2","author":"Yunusa","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/ph14030246","article-title":"Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics","volume":"14","author":"Calsolaro","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40266-014-0159-3","article-title":"Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study","volume":"31","author":"Ballokova","year":"2014","journal-title":"Drugs Aging"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jppr.1260","article-title":"Pharmacological management of behavioural and psychological symptoms of dementia","volume":"46","author":"Franchi","year":"2016","journal-title":"J Pharm Pract Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"CD008191","DOI":"10.1002\/14651858.CD008191.pub2","article-title":"Antidepressants for agitation and psychosis in dementia","volume":"2011","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"CD009178","DOI":"10.1002\/14651858.CD009178.pub4","article-title":"Pharmacotherapies for sleep disturbances in dementia","volume":"11","author":"McCleery","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.36150\/2499-6564-N320","article-title":"Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use","volume":"69","author":"Cuomo","year":"2021","journal-title":"J Gerontol Geriatr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1017\/S1041610211000743","article-title":"Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study","volume":"23","author":"Barak","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00127-023-02496-y","article-title":"Differential effects of healthcare worker burnout on psychotropic medication use and misuse by occupational level","volume":"59","author":"Hoopsick","year":"2024","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s11096-023-01645-2","article-title":"A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes","volume":"45","author":"Raza","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"ref48","year":"2021"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"11426","DOI":"10.3390\/ijerph191811426","article-title":"Potentially inappropriate medication use in patients with dementia","volume":"19","author":"Yoon","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref50","year":"2024"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1776066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:27:47Z","timestamp":1781497667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1776066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":50,"alternative-id":["10.3389\/fpubh.2026.1776066"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1776066","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1776066"}}